SEC Form 4 · accession 0001127602-17-030206
LABCORP HOLDINGS INC. · LH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
M. Huff Gary
Officer — CEO, LabCorp Diagnostics
Period of report
Sep 1, 2017
Accepted (ET)
Oct 23, 2017 · 4:10 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000920148
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Sep 1, 2017 | M | 153 | — | A | 400 | D | |
| Common StockF2 | Sep 1, 2017 | F | 51 | $157.61 | D | 349 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitF1,F5,F4 | — | Sep 1, 2017 | M | 153 | D | — | — | Common Stock | 153 | 14,037 | D |
Explanation of responses
- F1Each restricted stock unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.
- F2Amount includes 193.3653 shares acquired on June 30, 2017 under the Laboratory Corporation of America Holdings 2016 Employee Stock Purchase Plan.
- F3Stock withholding to satisfy tax withholding obligations.
- F4The Restricted Stock Units vest in three equal annual installments beginning on 9/1/17.
- F5This number reflects the aggregate number of Restricted Stock Units held by the reporting person.